• ARCHILLI, G., PEREGO, C. & PONZIO, F. (1985). Application of the dual-cell coulometric detector: a method for assaying monoamines and their metabolites. Anal. Biochem., 148, 19.
  • ANELLI, M., BIZZI, A., CACCIA, S., CODEGONI, A.M. FRACASSO, C. & GARATTINI, S. (1992). Anorectic activity of fluoxetine and norfluoxetine in mice, rats and guinea-pigs. J. Pharm. Pharmacol., 44, 696698.
  • BENFIELD, T. & WARD, A. (1986). Fluvoxamine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness. Drug, 32, 313334.
  • CACCIA, S., BIZZI, A., COLTRO, G., FRACASSO, C., FRITTOLI, E., MENNINI, T. & GARATTINI, S. (1992a). Anorectic activity of fluoxetine and norfluoxetine in rats: relationship between brain concentrations and in-vitro potencies on monoaminergic mechanisms. J. Pharm. Pharmacol., 44, 250254.
  • CACCIA, S., CAPPI, M., FRACASSO, C. & GARATTINI, S. (1990). Influence of dose and route of administration on the kinetics of fluoxetine and its metabolite norfluoxetine in the rat. Psychopharmacology (Berl), 100, 509514.
  • CACCIA, S., FRACASSO, C., GARATTINI, S., GUISO, G. & SARATI, S. (1992b). Effects of short- and long-term administration of fluoxetine on the monoamine content of rat brain. Neuropharmacology, 31, 343347.
  • DECHANT, K.L. & CLISSOLD, S.P. (1991). Paroxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depressive illness. Drugs, 41, 225253.
  • DeLEAN, A., MUNSON, P.J. & RODBARD, D. (1978). Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves. Am. J. Physiol., 235, E97E102.
  • FERGUSON, J.M. & FEIGHNER, J.P. (1987). Fluoxetine-induced weight loss in overweight non-depressed humans. Int. J. Obes., 11, Suppl. 3, 163170.
  • FOGLIA, J.P., BIRDER, L.A. & PEREL, J.M. (1989). Determination of fluvoxamine in human plasma by high-performance liquid chromatography with ultraviolet detection. J. Chromatogr., 495, 295302.
  • GARATTINI, S., BIZZI, A., CACCIA, S., MENNINI, T. & SAMANIN, R. (1988). Progress in assessing the role of serotonin in the control of food intake. Clin. Neuropharmacol., 11, Suppl. 1, S8S32.
  • GARATTINI, S., CACCIA, S., MENNINI, T. & SAMANIN, R. (1991). Progress report on drugs inducing anorexia by affecting brain serotonin. In Obesity and Cachexia: Physiological Mechanisms and New Approaches to Pharmacological Control. ed. ROTHWELL, N.J. & STOCK, M.J. pp. 227240. Chichester: Wiley.
  • GOBBI, M., FRITTOLI, E., MENNINI, T. & GARATTINI, S. (1992). Releasing activities of d-fenfluramine and fluoxetine on rat hippocampal synaptosomes preloaded with [3H]serotonin. Naunyn Schmied. Arch. Pharmacol., 345, 16.
  • JOHNSON, A.M. (1989). An overview of the animal pharmacology of paroxetine. Acta Psychiatr. Scand., 80, Suppl. 350, 1420.
  • KOE, B.K., WEISSMAN, A., WELCH, W.M. & BROWNE, R.G. (1983). Sertraline, 1S, 4S-N-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphtylamine, a new uptake inhibitor with selectivity for serotonin. J. Pharmacol. Exp. Ther., 226, 686700.
  • LEONARD, B.E. (1988). Pharmacological effects of serotonin reuptake inhibitors. J. Clin. Psychiatry, 49, Suppl., 1217.
  • MURDOCH, D. & McTAVISH, D. (1992). Sertraline. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depression and obsessive-compulsive disorder. Drugs, 44, 604624.
  • NATHAN, C. & ROLLAND, Y. (1987). Pharmacological treatments that affect CNS activity: serotonin. Ann. N.Y. Acad. Sci., 499, 277296.
  • ROSS, S.B., HALL, H., RENYI, A.L. & WESTERLUND, D. (1981). Effects of zimelidine on serotoninergic and noradrenergic neurons after repeated administration in the rat. Psychopharmacology (Berl), 72, 219225.
  • SAMANIN, R. & GARATTINI, S. (1990). The pharmacology of serotoninergic drugs affecting appetite. In Nutrition and the Brain, ed. WURTMAN, R.J. & WURTMAN, J.J. pp. 163192. New York: Raven Press.
  • SARKISSIAN, C.F., WURTMAN, R.J., MORSE, A.N. & GLEASON, R. (1990). Effect of fluoxetine or D-fenfluramine on serotonin release from, and levels in, rat frontal cortex. Brain Res., 529, 294301.
  • SCHMIDT, M.J., FULLER, R.W. & WONG, D.T. (1988). Fluoxetine, a highly selective serotinin reuptake inhibitor: a review of preclinical studies. Br. J. Psychiatry, 153, Suppl. 3, 4046.
  • SIMPSON, R.J., LAWTON, D.J., WATT, M.H. & TIPLADY, B. (1981). Effect of zimelidine, a new antidepressant, on appetite and body weight. Br. J. Clin. Pharmacol., 11, 9698.
  • SMEDEGAARD, J., CHRISTIANSEN, P. & SKRUMSAGER, B. (1981). Treatment of obesity by femoxetine a selective 5 HT reuptake inhibitor. Int. J. Obes., 5, 377378.
  • TREMAINE, L.M., WELCH, W.M. & RONFELD, R.A. (1989). Metabolism and disposition of the 5-hydroxytryptamine uptake blocker sertraline in the rat and dog. Drug. Metab. Dispos., 17, 542550.
  • WONG, D.T. & FULLER, R.W. (1987). Serotonergic mechanisms in feeding. Int. J. Obes., 11, Suppl. 3, 125133.